Ekso Bionics Holdings (FRA:23E2) Total Liabilities : €13.32 Mil (As of Dec. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Ekso Bionics Holdings Total Liabilities?

Ekso Bionics Holdings's Total Liabilities for the quarter that ended in Dec. 2024 was €13.32 Mil.

Ekso Bionics Holdings's quarterly Total Liabilities declined from Jun. 2024 (€13.87 Mil) to Sep. 2024 (€12.92 Mil) but then increased from Sep. 2024 (€12.92 Mil) to Dec. 2024 (€13.32 Mil).

Ekso Bionics Holdings's annual Total Liabilities increased from Dec. 2022 (€14.60 Mil) to Dec. 2023 (€14.96 Mil) but then declined from Dec. 2023 (€14.96 Mil) to Dec. 2024 (€13.32 Mil).

Ekso Bionics Holdings Total Liabilities Historical Data

The historical data trend for Ekso Bionics Holdings's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ekso Bionics Holdings Total Liabilities Chart

Ekso Bionics Holdings Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Liabilities

Get a 7-Day Free Trial

13.29

10.57

14.60

14.96

13.32

Ekso Bionics Holdings Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Liabilities	Get a 7-Day Free Trial															14.96	13.71	13.87	12.92	13.32

Ekso Bionics Holdings Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Ekso Bionics Holdings's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	7.198	+	(4.112	+	0.173
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	1.834	+	0	+	0)
	=	13.32

Total Liabilities	=	Total Assets (A: Dec. 2024 )	-	Total Equity (A: Dec. 2024 )
	=	25.453	-	12.135
	=	13.32

Ekso Bionics Holdings's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	7.198	+	(4.112	+	0.173
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	1.834	+	0	+	0)
	=	13.32

Total Liabilities	=	Total Assets (Q: Dec. 2024 )	-	Total Equity (Q: Dec. 2024 )
	=	25.453	-	12.135
	=	13.32

Ekso Bionics Holdings Total Liabilities Related Terms

Thank you for viewing the detailed overview of Ekso Bionics Holdings's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Ekso Bionics Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Ekso Bionics Holdings Inc (FRA:23E2) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

EKSO:USA 0IFR:UK

Address

101 Glacier Point, Suite A, San Rafael, CA, USA, 94901

Website

https://www.eksobionics.com

Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.

Ekso Bionics Holdings Headlines

No Headlines